|
|
 |
About Foresee Pharmaceuticals, Inc.
|
|
 |
Products We are Working On
FP-001-
Prostate Cancer
FP-002-
Acromegaly, Carcinoid tumors, and Diabetic Retinopathy
FP-004-
Substance Abuse and Pain Relief
FP-005-
Type 2 Diabetes
FP-025-
Asthma and COPD
|
Foresee's News
April 30th, 2011 - Foresee Pharmaceuticals,
Inc., a Delaware company, was spun-off from the research division of QPS
Holdings, LLC.
dadsfasddf
|
|
|
Foresee Pharmaceuticals, Inc. (FP) is an
emerging specialty pharmaceutical company built around a controlled-release
drug
delivery system for small molecules, peptides, and proteins to treat
chronic debilitating diseases and enable biotechnology products.ee
Pharmacdsafseuticals, LLC. (FP) is an emempany built aroua controlled-relpharmaceuticalpdfdsafsdfdsdfdsafsdfdl
|
 |
|
|
Drug Delivery Technologies
|
|
|
 |
|
|
|
Our Partnerships
On January 30th, 2013,
Foresee Pharmaceuticals, Inc. entered into a joint venture
agreement with ScinoPharm Taiwan, Ltd., a public traded
Traiwan based leading process R&D and API manufacturing
service provider to the global pharmaceutical industry.
|
|
|
|
Home
